AKT1 and Alzheimer disease: The observation clearly emphasized the upregulation of this mechanism, manifested as significantly (P < 0.05) amplified protein expressions of p-PI3K, p-Akt and p-mTOR to an approximately 2.17-, 2.97- and 2.6-fold increase, respectively, in the AD cohort vs controls (Figure 6).